Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that harnesses the wealth of advances in the fields of genomics and other omics (e.g., metabolomics, microbiomics, proteomics, transcriptomics, epigenomics, etc.) to incorporate these advances into translatable, personalized biobehavioral interventions for improved health outcomes.

Deadlines:

  • R01 Due Dates: Feb. 5, Jun 5, Oct. 5
  • AIDS Due Dates: Jan. 7, May 7, Sep. 7

PAR-19-377 Expiration Date January 8, 2023

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2022